Qiming's Leung on Investments in China's Biotech Industry

The video discusses the regulatory framework and investment strategies in the biotech sector, focusing on innovative drugs and market opportunities in China. It highlights the impact of regulatory reviews and cybersecurity on biotech companies, particularly in Hong Kong. The video also explores new developments in COVID-19 vaccines, including inhalation formulations. It examines trends in biotech IPOs and market growth, with a focus on the potential of Hong Kong as a leading biotech capital hub.

What are the main areas of focus for the companies mentioned in the text?

How many IPOs have occurred in the last 20 months according to the speaker?

What is the speaker's outlook on Hong Kong's position in global biotech capital raising?